The target countries of the initiative are 18 African countries .  

Egypt has been facing some difficulties in implementing the initiative, namely that some local Egyptian medicines are not registered in these countries and that PCR equipment is unavailable to analyze Hepatitis C before and after treatment ، these problems will be dealt with through sending several PCR equipment to these African countries, in addition to using local medicines approved by the World Health Organization.

The cost of the course with local medicines reaches LE800, while the price in America and Europe amounts to LE80,000,

The beginning will treat Hepatitis C and will extend to the treatment of Hepatitis B.

“The WHO offices in the 18 member countries will serve as technical leaders in these countries to contribute to comprehensive health coverage on the ground, It will also provide the necessary support to coordination meetings during the implementation steps to achieve the desired goal within the system of sustainable development and comprehensive health coverage to eliminate hepatitis by 2030